clinical trial · NCT06600607
Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults
Latigo Biotherapeutics·early phase1·completed·n = 20
Pain DetectionPain Thresholdpregabalin 300 mgPlacebo
brief summary
This is a randomized, double-blind, placebo-controlled within-participant crossover study in healthy male participants 18-55 years of age to assess pain tolerance during a cold pressor test. The study will be conducted at a single center in New Zealand.
started
Oct 7, 2024
primary completion
Oct 27, 2024
completion
Oct 27, 2024
last updated
May 4, 2025
official title
A Randomized, Double-Blind, Placebo-Controlled Crossover Study to Evaluate the Pharmacodynamic Effects of Pregabalin in Healthy Male Adults
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol